News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Glover Nicholas
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/12/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/06/2021 |
4
| Glover Nicholas (Director) has filed a Form 4 on MEI Pharma, Inc.|
Txns:
| Granted 50,000 options to buy
@ $2.95, valued at
$147.5k
|
|
| 07/07/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/27/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/03/2019 |
4
| Glover Nicholas (Director) has filed a Form 4 on MEI Pharma, Inc.|
Txns:
| Granted 40,000 options to buy
@ $2.52, valued at
$100.8k
|
|
| 03/05/2019 |
4
| Glover Nicholas (CEO and President) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Granted 607,500 options to buy
@ $1.96, valued at
$1.2M
|
|
| 07/16/2018 |
4
| Glover Nicholas (Director) has filed a Form 4 on MEI Pharma, Inc.|
Txns:
| Granted 40,000 options to buy
@ $4.28, valued at
$171.2k
|
|
| 03/07/2018 |
4
| Glover Nicholas (CEO and President) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Granted 562,780 options to buy
@ $2.36, valued at
$1.3M
|
|
| 07/10/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/08/2017 |
4
| Glover Nicholas (CEO and President) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Granted 195,000 options to buy
@ $1.45, valued at
$282.8k
|
|
| 10/04/2016 |
4
| Glover Nicholas (CEO and President) has filed a Form 4 on ProNAi Therapeutics Inc|
Txns:
| Granted 500,000 options to buy
@ $1.82, valued at
$910k
|
|
| 08/01/2016 |
4
| Glover Nicholas (Director) has filed a Form 4 on MEI Pharma, Inc.|
Txns:
| Granted 40,000 options to buy
@ $1.36, valued at
$54.4k
|
|
| 03/10/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/17/2013 |
4
| Glover Nicholas (Director) has filed a Form 4 on MEI Pharma, Inc.|
Txns:
| Granted 6,730 options to buy
@ $7.43, valued at
$50k
|
|
| 06/11/2013 |
4
| Glover Nicholas (Director) has filed a Form 4 on MEI Pharma, Inc.|
Txns:
| Granted 4,063 options to buy
@ $8.09, valued at
$32.9k
|
|
|
|